President | Chief Medical Officer
Prof. Andy Goren has over 15 years of experience in research, development and launch of breakthrough medical technologies.
Among the list of many firsts in dermatology, Prof. Goren was the first to develop a clinical genetic test for predicting androgenetic alopecia, the first to discover epigenetic markers predicting anti-androgen therapy response in female androgenetic alopecia, the first to develop a clinical acne vulgaris antibiotic response test based on P. Acnes bacterial genomics, and the first to develop a rapid test for predicting minoxidil response in androgenetic alopecia.
Prof. Goren recently completed the development, commercialization, and listing with the U.S. FDA of a breakthrough topical drug for vitiligo, psoriasis and atopic dermatitis. His latest research involves the development of dermatology therapies based on genetically modified organisms.
Prof. Goren currently serves as a Professor of Dermatology at the University of Rome "G.Marconi", Italy. He is an honorary as well as ordinary member of several dermatology societies world-wide, a scientific reviewer for Dermatologic Therapy, a lecturer in several international dermatology societies, and held numerous appearances and interviews on mainstream TV, radio, and prestigious newspapers. His accomplishments include numerous patents and publications related to his inventions and discoveries. Prior to his work in Dermatology, Professor Goren developed a medical device to correct gait disorders in peripheral neuropathy patients using sensory substitution, as well as invent the first wire-free electric charger for mobile devices.
Dr. Sharon Keene is a board certified general surgeon, who completed her surgical training at the University of Arizona in Tucson. She has subsequently specialized in the medical and surgical treatment of hair loss for men and women.
For the past 2 decades she has gained professional acclaim, using her surgical knowledge to advance techniques and improve cosmetic outcomes. Dr. Keene has shared her expertise through lecturing, teaching and authorship of medical articles and has received many professional awards for her work in hair restoration. She has been actively involved in research to improve diagnosis and treatment of female hair loss, by co-developing and co-authoring a pilot study on epigenetic influences on the androgen receptor gene and response to finasteride therapy in female hair loss. Since the completion of that project, she has written and lectured on the various environmental and dietary influences that may be affecting human epigenetics and increasing the rate and expression of androgenetic alopecia. Additionally, Dr. Keene has developed surgical instruments and tools to improve the ergonomics and efficiency of surgery.
As part of her commitment to peer education, she has participated in various capacities and on various educational committees for the International Society of Hair Restoration Surgeons (ISHRS) including: scientific chairman for the annual scientific committee (2007), chairman of the evidence based medicine task force (2009-10), member continuing medical education committee, current chairman of the finance committee and member of the expert subcommittee panel on best practices. She is currently the treasurer and an active member of the ISHRS executive committee. Dr. Keene served as chief medical officer for Dermagenoma from 2008-11, a medical genomics company which provided genetic tests related to diagnosis and treatment of dermatologic and associated conditions such as androgenetic alopecia, psoriatic arthritis, etc. She also serves in a pro bono capacity as a member of the health authority advisory board to a small rural clinic, Elbowoods Memorial Health Center, in North Dakota. She currently practices hair restoration surgery at Physician’s Hair Institute in Tucson, AZ.
Director of Research & Development
Dr. John McCoy is part of the research and development team at Applied Biology. He has over 10 years of laboratory research experience at many of California's premier institutions, including UCLA, UCSD and UC Berkeley.
Dr. McCoy has authored several original patents and scholarly articles for publication in peer-reviewed scientific journals. He is a member of the American Chemical Society and the Biophysical Society. Dr. McCoy was a postdoctoral fellow at the Jules Stein Eye Institute (UCLA) where he was the recipient of the prestigious Gerald Oppenheimer Post Doctoral Fellowship and the National Institutes of Heath Vision Science Training Grant. Currently, Dr. McCoy's research is focused on the development of Photocil, a novel topical drug for the treatment of vitiligo, psoriasis and atopic dermatitis. In addition, Dr. McCoy is developing new therapies for dermatology based on genetically modified organisms.
Director of Marketing & Creative
As Director of Marketing / Creative for Applied Biology, Ms. Wolf oversees the establishment and execution of Applied Biology’s marketing strategy, brand identity, web site design, packaging, advertising campaigns, and corporate communications.
Lorie has over 20 years experience in advertising, design, and marketing and has received a host national awards for her outstanding work in art direction. Ms. Wolf has built a highly successful consulting career with a top-tier clients, including DermaGenoma, Microsoft, dwell Magazine, Hilton Hotels, Sea World, San Diego Padres, Providian Financial, Warner Brothers, O’Donnell/Atkins, Johnson Capital, IDG, CMP, Sun Microsystems, Miller Freeman Publishing and more. In her spare time, Lorie is the executive director (at large) for Pandarin Academy, a Chinese school based in Orange County, California. Ms. Wolf obtained a Bachelor’s Degree in Fine Arts from the University of Arizona.